Colorectal Cancer Trial, Recruiting NCT07143487 Sponsor: Alliance for Clinical Trials in Oncology Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07143487
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the main participants (called "probands") — Step 1:

  • Adults aged 18 or older who have been newly diagnosed with primary colorectal cancer (colon or rectal cancer) within the last 3 months, at any stage from Stage I to Stage IV
  • People whose cancer has been confirmed by laboratory testing as a colon or rectal adenocarcinoma, including cases where the tumor involves nearby areas such as the small bowel
  • People with more than one primary colon cancer diagnosis at the same time
  • People who have had other cancers in the past, including non-invasive cancers, or who currently have a second cancer alongside their colorectal cancer
  • People who have not had germline (inherited gene) testing in the past 2 years and do not already have a known hereditary colon cancer syndrome
  • People who have at least 2 living close family members (parents, siblings, or children) who also meet the trial's eligibility requirements, and who are willing to share their cancer diagnosis with those family members
  • People who can speak and read English or Spanish, as this is required to complete study materials and receive genetic education
  • People who do not have a known diagnosis of dementia, cognitive impairment, or a psychiatric or developmental condition that significantly affects their ability to understand information and make decisions — eligibility on this point is determined by the treating doctor

For the main participants — Step 2:

  • Probands who have tested positive for a harmful inherited gene change (called a pathogenic germline variant) in a cancer-related gene

For close family members (called "FDRs" — first-degree relatives):

  • Adults aged 18 or older who are a parent, sibling, or child of the main participant
  • People who have not previously had germline (inherited gene) testing and do not already have a known hereditary colon cancer syndrome
  • People who live within the United States, as the genetic testing used in this trial is only available to US residents
  • People who can speak and read English or Spanish, as this is required to complete study materials

Who may not be able to join:

  • People diagnosed with Stage 0 or in-situ colorectal cancer (the earliest form, where cancer cells have not spread beyond the original tissue layer)
  • People who have already had germline genetic testing within the past 2 years, or who already have a known hereditary colon cancer syndrome
  • People who do not have at least 2 living close family members who also meet the trial's eligibility requirements, or who are unwilling to share their diagnosis with those family members
  • People who are unable to speak or read English or Spanish
  • People with a known diagnosis of dementia, cognitive impairment, or a psychiatric or developmental condition that significantly affects judgment and reasoning — the treating doctor makes this determination
  • Family members who live outside the United States

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Frank A Sinicrope, Alliance for Clinical Trials in Oncology

Phone: 773-702-9814

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 April 2026
Est. completion
5 November 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of eligible first-degree relatives (FDRs) of the affected proband who underwent genetic testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov